Inventor · disambiguated record
Duane A. Burnett
Also filed as: BURNETT DUANE · BURNETT DUANE A
63 granted patents·17 pending applications·1,366 citations·filing 1994–2022
99Inventor score
Files withSCHERING CORP45ARKUDA THERAPEUTICS5WU WEN-LIAN5FORUM PHARMACEUTICALS INC4AQUINNAH PHARMACEUTICALS INC3
Top patents by PatentIndex Score
80 records- 0198US5767115AHydroxy-substituted azetidinone compounds useful as hypocholesterolemic agentsSCHERING PLOUGH CORP·Filed 1996·Granted Jun 16, 1998·267 cites·9 claims
- 0297USRE37721EHydroxy-substituted azetidinone compounds useful as hypocholesterolemic agentsSCHERING CORP·Filed 2000·Granted May 28, 2002·99 cites·13 claims
- 0397US5846966ACombinations of hydroxy-substituted azetidinone compounds and HMG CoA Reductase InhibitorsSCHERING CORP·Filed 1997·Granted Dec 8, 1998·171 cites·10 claims
- 0497US5656624A4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agentsSCHERING CORP·Filed 1994·Granted Aug 12, 1997·115 cites·3 claims
- 0596US5624920ASulfur-substituted azetidinone compounds useful as hypocholesterolemic agentsSCHERING CORP·Filed 1994·Granted Apr 29, 1997·88 cites·15 claims
- 0695US5744467ASulfur-substituted azetidinone compounds useful as hypocholesterolemic agentsSCHERING CORP·Filed 1997·Granted Apr 28, 1998·77 cites·12 claims
- 0795US5698548ASpirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agentsSCHERING CORP·Filed 1995·Granted Dec 16, 1997·88 cites·12 claims
- 0895US5688787ASubstituted β-lactam compounds useful as hypochlesterolemic agents and processes for the preparation thereofSCHERING CORP·Filed 1996·Granted Nov 18, 1997·90 cites·7 claims
- 0994US7884080B2Azetidinone derivatives and methods of use thereofSCHERING PLOUGH CORP·Filed 2007·Granted Feb 8, 2011·46 cites·23 claims
- 1091US9226927B2Gamma secretase inhibitorsWU WEN-LIAN·Filed 2012·Granted Jan 5, 2016·8 cites·12 claims
- 1191US7482360B2Fused tetracyclic mGluR1 antagonists as therapeutic agentsSCHERING CORP·Filed 2006·Granted Jan 27, 2009·15 cites·23 claims
- 1291US6664273B2Piperidine based MCH antagonists for treatment of obesity and CNS disordersSCHERING CORP·Filed 2002·Granted Dec 16, 2003·45 cites·29 claims
- 1391US5633246ASulfur-substituted azetidinone compounds useful as hypocholesterolemic agentsSCHERING CORP·Filed 1995·Granted May 27, 1997·91 cites·15 claims
- 1489US7368562B2Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereofSCHERING CORP·Filed 2007·Granted May 6, 2008·10 cites·32 claims
- 1584US8987195B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Mar 24, 2015·9 cites·27 claims
- 1684US7208486B2Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereofSCHERING CORP·Filed 2004·Granted Apr 24, 2007·16 cites·22 claims
- 1784US6632933B2Use of azetidinone compoundsSCHERING CORP·Filed 2001·Granted Oct 14, 2003·18 cites·3 claims
- 1884US6593078B1Use of azetidinone compoundsSCHERING CORP·Filed 2000·Granted Jul 15, 2003·11 cites·6 claims
- 1983US9365589B2C5, C6 oxacyclic-fused thiazine dioxide compounds as BACE inhibitors, compositions, and their useMERCK SHARP & DOHME·Filed 2013·Granted Jun 14, 2016·7 cites·14 claims
- 2083US8664411B2Tetrahydropyranochromene gamma secretase inhibitorsWU WEN-LIAN·Filed 2008·Granted Mar 4, 2014·8 cites·23 claims
- 2183US8450343B2Gamma secretase modulatorsHUANG XIANHAI·Filed 2008·Granted May 28, 2013·9 cites·8 claims
- 2283US7235543B2Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereofSCHERING CORP·Filed 2004·Granted Jun 26, 2007·13 cites·21 claims
- 2380US8067621B2Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitorsASBEROM THEODROS·Filed 2007·Granted Nov 29, 2011·5 cites·48 claims
- 2478US7459442B2Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereofSCHERING CORP·Filed 2008·Granted Dec 2, 2008·3 cites·28 claims
- 2578US7109207B2Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesitySCHERING CORP·Filed 2003·Granted Sep 19, 2006·13 cites·22 claims
- 2676US11542233B2Compounds, compositions and methods of useAQUINNAH PHARMACEUTICALS INC·Filed 2017·Granted Jan 3, 2023·1 cites·27 claims
- 2776US7598259B2mGluR1 antagonists as therapeutic agentsSCHERING CORP·Filed 2005·Granted Oct 6, 2009·2 cites·10 claims
- 2875US9499502B25-substituted iminothiazines and their mono- and dioxides as BACE inhibitors, compositions, and their useWU WEN-LIAN·Filed 2012·Granted Nov 22, 2016·3 cites·18 claims
- 2975US8933116B2Gamma secretase inhibitorsWU WEN-LIAN·Filed 2012·Granted Jan 13, 2015·1 cites·15 claims
- 3074US7687501B2Pyridothienopyridazinone derivatives as mGluR1 antagonistsSCHERING CORP·Filed 2006·Granted Mar 30, 2010·2 cites·32 claims
- 3173US9453034B2C2-azaspiro iminothiazine dioxides as BACE inhibitors, compositions, and their useMERCK SHARP & DOHME·Filed 2014·Granted Sep 27, 2016·2 cites·12 claims
- 3272US7902157B2Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolismSCHERING CORP·Filed 2007·Granted Mar 8, 2011·1 cites·23 claims
- 3371US8618123B2Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitorsSASIKUMAR THAVALAKULAMGARA K·Filed 2008·Granted Dec 31, 2013·3 cites·18 claims
- 3471US8569521B2Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitorsASBEROM THEODROS·Filed 2011·Granted Oct 29, 2013·2 cites·64 claims
- 3571US7485648B2mGluR1 antagonists as therapeutic agentsSCHERING CORP·Filed 2005·Granted Feb 3, 2009·1 cites·20 claims
- 3671US7214691B22-substituted benzimidazole derivatives as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disordersSCHERING CORP·Filed 2004·Granted May 8, 2007·6 cites·25 claims
- 3770US7192944B2Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereofSCHERING CORP·Filed 2004·Granted Mar 20, 2007·4 cites·29 claims
- 3867US7723020B2Use of azetidinone compoundsSCHERING CORP·Filed 2006·Granted May 25, 2010·0 cites·6 claims
- 3967US7144696B2Use of azetidinone compoundsSCHERING CORP·Filed 2005·Granted Dec 5, 2006·1 cites·4 claims
- 4065US7741289B2Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereofSCHERING CORP·Filed 2008·Granted Jun 22, 2010·0 cites·20 claims
- 4165US7030113B2Aminobenzimidazoles as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disordersSCHERING CORP·Filed 2004·Granted Apr 18, 2006·2 cites·42 claims
- 4265US2023303489A1Compounds, compositions and methods of useAQUINNAH PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4364US9181236B22-spiro-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions and their useWU WEN-LIAN·Filed 2012·Granted Nov 10, 2015·1 cites·15 claims
- 4464US8691832B2Tricyclic heterocycles useful as dipeptidyl peptidase-IV inhibitorsBURNETT DUANE A·Filed 2011·Granted Apr 8, 2014·2 cites·17 claims
- 4564US7989464B2mGluR1 antagonists as therapeutic agentsSCHERING CORP·Filed 2009·Granted Aug 2, 2011·0 cites·11 claims
- 4663US7732413B2Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereofSCHERING CORP·Filed 2008·Granted Jun 8, 2010·0 cites·21 claims
- 4762US7504391B2Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disordersSCHERING CORP·Filed 2004·Granted Mar 17, 2009·1 cites·26 claims
- 4862US7211574B2Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disordersSCHERING CORP·Filed 2003·Granted May 1, 2007·1 cites·16 claims
- 4961US7368563B2Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereofSCHERING CORP·Filed 2007·Granted May 6, 2008·0 cites·22 claims
- 5060US2012129846A1Gamma secretase modulatorsZHU ZHAONING·Filed 2009·Application pending·0 cites
Showing the top 50 of 80 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →